Marijuana Matters Presents Cannabinoids and Sickle Cell Disease
Friday, September 2, 2022
1:00 PM 2:00 PM
Sickle cell disease (SCD), which affects approximately 8% of African Americans, is characterized by chronic pain and episodic acute pain caused by Vaso occlusive crises, often requiring high doses of opioids for prolonged periods. Evidence is growing that cannabis may help people manage pain from SCD. However, only nine states include sickle cell as an approved health condition for medical marijuana.
We plan to speak with caregivers of individuals that have SCD that are advocates of medical cannabis.
Please register using the form link below.